Clearstead Trust LLC Buys 652 Shares of CME Group Inc. (NASDAQ:CME)

Clearstead Trust LLC raised its holdings in CME Group Inc. (NASDAQ:CME) by 27.0% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,066 shares of the financial services provider’s stock after buying an additional 652 shares during the quarter. Clearstead Trust LLC’s holdings in CME Group were worth $603,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CME. Gold Investment Management Ltd. acquired a new stake in CME Group in the 4th quarter valued at approximately $26,000. Salomon & Ludwin LLC acquired a new stake in shares of CME Group during the 1st quarter worth approximately $28,000. Y.D. More Investments Ltd acquired a new stake in shares of CME Group during the 2nd quarter worth approximately $36,000. McClarren Financial Advisors Inc. grew its holdings in shares of CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares in the last quarter. Finally, Asset Dedication LLC grew its holdings in shares of CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft lifted their price objective on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. JPMorgan Chase & Co. lifted their price objective on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Bank of America lowered CME Group from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $212.00 to $177.00 in a report on Tuesday, September 3rd. Piper Sandler reissued an “overweight” rating and set a $225.00 price objective on shares of CME Group in a report on Tuesday, August 20th. Finally, Keefe, Bruyette & Woods raised their target price on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Four equities research analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, CME Group has an average rating of “Hold” and a consensus target price of $209.73.

Insider Buying and Selling at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.30% of the company’s stock.

CME Group Trading Up 0.7 %

Shares of CME opened at $218.53 on Tuesday. The stock has a fifty day moving average price of $206.16 and a two-hundred day moving average price of $207.48. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $223.80. The company has a market cap of $78.69 billion, a price-to-earnings ratio of 24.86, a PEG ratio of 8.85 and a beta of 0.55.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter in the previous year, the company posted $2.30 EPS. The business’s revenue for the quarter was up 12.7% compared to the same quarter last year. Analysts predict that CME Group Inc. will post 9.94 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be given a $1.15 dividend. The ex-dividend date is Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.10%. CME Group’s payout ratio is 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.